Last reviewed · How we verify
SSRI with Zinc Sulfate — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
SSRI with Zinc Sulfate (SSRI with Zinc Sulfate) — Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| SSRI with Zinc Sulfate TARGET | SSRI with Zinc Sulfate | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- SSRI with Zinc Sulfate CI watch — RSS
- SSRI with Zinc Sulfate CI watch — Atom
- SSRI with Zinc Sulfate CI watch — JSON
- SSRI with Zinc Sulfate alone — RSS
Cite this brief
Drug Landscape (2026). SSRI with Zinc Sulfate — Competitive Intelligence Brief. https://druglandscape.com/ci/ssri-with-zinc-sulfate. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab